Keyphrases
Malignant Peripheral Nerve Sheath Tumor (MPNST)
100%
Positron Emission tomography-CT
100%
18F-FDG Positron Emission Tomography
100%
Metabolic Tumor Volume
50%
Conventional Imaging
41%
SUVmax
41%
Total Lesion Glycolysis
41%
Restaging
33%
Imaging Studies
16%
Outcome Prediction
16%
Computational Imaging
16%
Tumor Patients
16%
Chart Review
16%
CT Findings
16%
MD Anderson Cancer Center
16%
Standardized Uptake Value
16%
SUVmean
16%
Clinical Outcomes
8%
Treatment Strategy
8%
High Sensitivity
8%
Significant Predictors
8%
Disease Stage
8%
Prognostic Factors
8%
Response Prediction
8%
Clinical Treatment
8%
Progression-free Survival
8%
University of Texas
8%
Local Recurrence
8%
Treatment Planning
8%
CT Studies
8%
Distant Metastasis
8%
Treatment Change
8%
Residual Tumor
8%
Tumour Changes
8%
Overall Survival Progression-free Survival
8%
Tumor Management
8%
National Comprehensive Cancer Network Guidelines
8%
Baseline Staging
8%
Medicine and Dentistry
Positron Emission Tomography
100%
Malignant Peripheral Nerve Sheath Tumor
100%
Fluorodeoxyglucose F 18
100%
Neoplasm
58%
Conventional Imaging
41%
Malignant Neoplasm
25%
Recurrent Disease
16%
Progression Free Survival
16%
Disease
8%
Overall Survival
8%
Prognostic Factor
8%
Distant Metastasis
8%
Treatment Planning
8%
Standardized Uptake Value
8%